Breaking News

Clash over online Adderall prescriptions raises telehealth questions; cracking the mystery of viral hepatitis cases in kids

    

 

Daily Recap

A clash over online Adderall prescriptions is raising new questions about telehealth

By Mohana Ravindranath

Adobe

Online pharmacy startups have pledged to make it faster and easier than ever to get needed medications for ADHD and other conditions.

Read More

With usual suspects ruled out, disease detectives try to crack mystery of viral hepatitis cases in kids

By Helen Branswell

Dr. Erskine Palmer/CDC via AP

While they still don't have solid answers, experts are assembling evidence in an investigation that spans state and national borders.

Read More

STAT+: Researchers describe the human element in the alchemy behind the Moderna vaccine and other new medicines

By Matthew Herper

Above Summit for STAT

At a STAT event, drug and vaccine developers spoke about the scientific and psychological issues involved in the highly technical process.

Read More

Opinion: Listen: How should doctors treat chronic pain in the wake of the opioid crisis?

By Patrick Skerrett

Clinicians walk a tightrope when trying to help people living with chronic pain. Two physicians describe what it's like.

Read More

STAT+: Race is often overlooked in key clinical trial data used to win new drug approvals in Europe

By Ed Silverman

Molly Ferguson for STAT

Just two-thirds of the pivotal clinical trials that were used to win prescription drug approvals in Europe reported data on participant race.

Read More

Opinion: Should clinicians use emojis when they communicate with each other?

By Rodrigo Martínez

Adobe

Emojis may be ubiquitous online, but their use in clinician-to-clinician interactions is not. Employing them could improve communication.

Read More

STAT+: FDA warns Miami University contract testing lab over falsified data, poor quality control

By Ed Silverman

Andrew Harnik/AP

"The results are not reliable, reportable, or suitable to support the quality of heparin drug or drug products," the FDA wrote to the school.

Read More

Wednesday, May 4, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments